Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Wall Street Journal

Home/Tag:Wall Street Journal
9 03, 2013

Wall Street Journal features article about new myeloma therapies

Tags: , , , , , , , |7 Comments

A good friend of mine, long-lived myeloma survivor Paula Van Riper, was recently featured in an excellent Wall Street Journal article about the recent FDA approvals of Kyprolis and Pomalyst.  The IMF's Medical Director, Dr. Brian Durie, is interviewed, along with Dr. David Siegel, chief of the myeloma division at John Theurer Cancer Center in

5 06, 2012

Newspapers and network news jumping-on immunotherapy bandwagon

Tags: , , , |0 Comments

  Do you remember my articles and posts about immunotherapies at this year’s ASCO in Chicago? How could you have missed them?  I ran three articles on HelpWithCancer.org (HWC) this weekend and two more on this site.  And that doesn’t include this morning’s multiple myeloma immuno specific post about the surprising new monoclonal protein, daratumumab.

27 08, 2010

Are Sky High Anti-Myeloma Drug Prices Justified?

Tags: , , , , , , |2 Comments

Yesterday I provided you with a link to a Wall Street Journal article about the high cost of thalidomide, How Drug's Rebirth as Treatment For Cancer Fueled Price Rises: Once-Demonized Thalidomide Boosts Celgene's Sales; Patients See Costs Soar, by Geeta Anand.Anyone notice when this article was written? November 15, 2004! Six years ago patients were